Cross-reactive influenza A immunization

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4242041, 4241841, 530350, 536 231, A61K 39145, A61K 3900, C07K 100, C07H 2102

Patent

active

058826505

ABSTRACT:
This disclosure relates to methods and compositions for stimulating in an individual an influenza A virus protective response which is subtype cross-protective. Influenza A virus NS1 protein, or a T cell epitope thereof, is administered to the individual in an amount sufficient to stimulate the virus protective response.

REFERENCES:
patent: 4803072 (1989-02-01), Dalton et al.
Wraith, D.C., et al., "Purified Influenza Virus Nucleoprotein Protects Mice from Lethal Infection," J. Gen. Virol., 68:433-440 (1987).
Bennink, J.R., et al., "Anti-Influenza Virus Cytotoxic T Lymphocytes Recognize the Three Viral Polymerases and a Nonstructural Protein: Responsiveness to Individual Viral Antigens Is Major Histocompatibility Complex Controlled," J. Gen. Virol., 61:1098-1102 (1987).
Yamada, A., et al., "Influenza Virus Hemagglutinin-Specific Cytotoxic T Cell Response Induced by Polypeptide Produced in Escherichia coli," J. Exp. Med., 162:663-674 (1985).
Kuwano, K., et al., "Active Immunization Against Virus Infections Due to Antigenic Drift by Induction of Crossreactive Cytotoxic T Lymphocytes," J. Exp. Med., 169:1361-1371 (1989).
Kuwano, K., et al., "HA2 Subunit of Influenza A H1 and H2 Subtype Viruses Induces a Protective Cross-Reactive Cytotoxic T Lymphocyte Response," J. Immunol., 140:1264-1268 (1988).
Kuwano, K., et al., "Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone," Immunochemistry, 113:499 (1990). (From Chem. Abstracts, Abstract No. 130459C).
Kingsman, Genetic Engineering Chapter 12, Blackwell Scientific Publications (Oxford, GB), 1988.
Young, et al., "Efficient Expression of Influenza Virus NS1 . . . " PNAS 80:6105-6109 (1983).
Smith, G.L., et al., "Synthesis and Cellular Location of Ten Influenza Polypeptides Individually Expressed by Recombinant Vaccinia Viruses," Virology, 160:336-345 (1987).
Shaw, M.W., et al., "Immunologic Studies on the Influenza A Virus Nonstructural Protein NS.sub.1," J. Exp. Med., 156:243-254 (1982).
Kuwano, K., et al., "Cross-Reactive Protection against Influenza A Virus Infections by an NS1-Specific CTL Clone," Virology, 178:174-179 (1990).
Cossins, J., et al., "Precise Prediction of a K.sup.k -Restricted Cytotoxic T Cell Epitope in the NS1 Protein of Influenza Virus Using an MHC Allele-Specific Motif," Virology, 193:289-295 (1993).
Hackett, C.J., et al., "Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein," J. of General Virology, 73:1339-1343 (1992).
Bennink, J.R. and Yewdell, J.W., "Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles," J. Exp. Med., 168(5):1935-1939 (1988).
Bennink, et al, "Anti-Influenza Virus Cytotoxic T Lymphocytes . . . " J. Virol. 61(4):1098-1102, 1987.
Kuwano, et al, "Cross-Reactive Protection against Influenza A Virus . . . " Virology 178:174-179, 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cross-reactive influenza A immunization does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cross-reactive influenza A immunization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-reactive influenza A immunization will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-814865

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.